Featured Research

from universities, journals, and other organizations

Team approach results in dramatic improvement in timely heart attack care

Date:
December 3, 2009
Source:
Yale University
Summary:
Health care professionals using new time-saving strategies to coordinate care for patients having a heart attack saw dramatic improvement in "door-to-balloon" times -- the time from when a patient enters the hospital to the time blood flow is restored to the heart by opening a blockage with angioplasty. The faster patients are treated, the more likely they are to survive.

Healthcare professionals using new time-saving strategies to coordinate care for patients having a heart attack saw dramatic improvement in "door-to-balloon" (D2B) times -- the time from when a patient enters the hospital to the time blood flow is restored to the heart by opening a blockage with angioplasty. The faster patients are treated, the more likely they are to survive.

The results are published by Yale researchers and their colleagues in the December 15 issue of the Journal of the American College of Cardiology.

The D2B Alliance, a national campaign sponsored by the American College of Cardiology, and 38 partner organizations have set a goal of 75 percent of patients receiving life-saving heart attack care within 90 minutes of hospital arrival.

Less than half of hospitals surveyed in the study met clinical guidelines in door-to-balloon times in 2005. Today, more than 80 percent are meeting the guidelines, according to the most recent data from the National Cardiovascular Data Registry (NCDR).

The Yale team surveyed D2B times in 831 hospitals participating in the NCDR CathPCI Registry from April 1, 2005 to March 31, 2008. The survey showed marked reductions in unnecessary delays in treatment and widespread adoption of recommended strategies to improve care. The improvement was seen across the nation, not just in select hospitals or states.

Some examples of strategies to reduce delays in door-to-balloon times include emergency medicine staff activating the catheterization laboratory with a single call, expectations to have the catheterization team be in the laboratory within 20-30 minutes of being paged, and providing prompt data feedback to staff about door-to-balloon times.

"The key is to have a leader and a team devoted to a single goal and to be persistent, even in the face of setbacks," said first author Elizabeth Bradley, professor of public health at the Yale School of Public Health. "This campaign has changed the way heart attack care is delivered -- for the benefit of patients."

Senior author on the study Harlan M. Krumholz, M.D., the Harold H. Hines, Jr. Professor of Medicine and Public Health at Yale School of Medicine, said that patients are now being treated so rapidly that in some cases the heart attack is aborted, damage is avoided and patients rapidly experience a full recovery. "This remarkable leap in performance is a tribute to the nation's interventional cardiologists and other healthcare professionals who quickly adopted effective systems that were developed by NIH-sponsored research," he said.

"Most of what we read about in healthcare reform is about healthcare financing," Bradley said. "This effort shows that the way care is organized can have tremendous impact, and with relatively little added resources."

Other authors on the study include Brahmajee K. Nallamothu, M.D., Jeph Herrin, Henry H. Ting, M.D., Amy F. Stern, Ingrid M. Nembhard, Christina T. Yuan, Jeremy C. Green, Eva Kline-Rogers, Yongfei Wang, Jeptha P. Curtis, M.D., Tashonna R. Webster, Frederick A. Masoudi, M.D., Gregg C. Fonarow, M.D. and John E. Brush, Jr., M.D.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elizabeth H. Bradley, Brahmajee K. Nallamothu, Jeph Herrin, Henry H. Ting, Amy F. Stern, Ingrid M. Nembhard, Christina T. Yuan, Jeremy C. Green, Eva Kline-Rogers, Yongfei Wang, Jeptha P. Curtis, Tashonna R. Webster, Frederick A. Masoudi, Gregg C. Fonarow, John E. Brush Jr, and Harlan M. Krumholz. National Efforts to Improve Door-to-Balloon Time: Results From the Door-to-Balloon Alliance. Journal of the American College of Cardiology, Expedited Publication: December 2, 2009 DOI: 10.1016/j.jacc.2009.11.003

Cite This Page:

Yale University. "Team approach results in dramatic improvement in timely heart attack care." ScienceDaily. ScienceDaily, 3 December 2009. <www.sciencedaily.com/releases/2009/12/091202172207.htm>.
Yale University. (2009, December 3). Team approach results in dramatic improvement in timely heart attack care. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/12/091202172207.htm
Yale University. "Team approach results in dramatic improvement in timely heart attack care." ScienceDaily. www.sciencedaily.com/releases/2009/12/091202172207.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins